Gene · 53335
Papers3,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene Therapy and Gene Editing for β-Thalassemia. | Hematol Oncol Clin North Am | 2023 | 36907613 | PubTator, text mining | PubMed |
| Fetal Hemoglobin Regulation in Beta-Thalassemia. | Hematol Oncol Clin North Am | 2023 | 36907604 | PubTator, text mining | PubMed |
| Molecular Basis and Genetic Modifiers of Thalassemia. | Hematol Oncol Clin North Am | 2023 | 36907603 | PubTator, text mining | PubMed |
| Associations of genetic markers of diabetes mellitus with carotid atherosclerosis: a community-based case-control study. | Cardiovasc Diabetol | 2023 | 36894991 | PubTator, text mining | PubMed |
| Induction of fetal hemoglobin: Lentiviral shRNA knockdown of HBS1L in β0-thalassemia/HbE erythroid cells. | PLoS One | 2023 | 36888630 | PubTator, text mining | PubMed |
| Combinatorial targeting of epigenome-modifying enzymes with decitabine and RN-1 synergistically increases HbF. | Blood Adv | 2023 | 36884303 | PubTator, text mining | PubMed |
| Improving adenine and dual base editors through introduction of TadA-8e and Rad51DBD. | Nat Commun | 2023 | 36869044 | PubTator, text mining | PubMed |
| Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy. | Cancer Gene Ther | 2023 | 36854897 | PubTator, text mining | PubMed |
| Forced enhancer-promoter rewiring to alter gene expression in animal models. | Mol Ther Nucleic Acids | 2023 | 36852088 | PubTator, text mining | PubMed |
| Nucleated red blood cells explain most of the association between DNA methylation and gestational age. | Commun Biol | 2023 | 36849614 | PubTator, text mining | PubMed |
| SWI/SNF Complex Genomic Alterations as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Multiple Cancers. | Cancer Immunol Res | 2023 | 36848524 | PubTator, text mining | PubMed |
| Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet. | Hemasphere | 2023 | 36844183 | PubTator, text mining | PubMed |
| In Silico Analysis of Publicly Available Transcriptomic Data for the Identification of Triple-Negative Breast Cancer-Specific Biomarkers. | Life (Basel) | 2023 | 36836779 | PubTator, text mining | PubMed |
| Association between Glutathione S-Transferases Gene Variants and COVID-19 Severity in Previously Vaccinated and Unvaccinated Polish Patients with Confirmed SARS-CoV-2 Infection. | Int J Environ Res Public Health | 2023 | 36834445 | PubTator, text mining | PubMed |
| Copy Number Variations in Children with Tourette Syndrome: Systematic Investigation in a Clinical Setting. | Genes (Basel) | 2023 | 36833427 | PubTator, text mining | PubMed |
| Investigation of UTR Variants by Computational Approaches Reveal Their Functional Significance in PRKCI Gene Regulation. | Genes (Basel) | 2023 | 36833174 | PubTator, text mining | PubMed |
| Gene Expression and Epigenetic Regulation in the Prefrontal Cortex of Schizophrenia. | Genes (Basel) | 2023 | 36833173 | PubTator, text mining | PubMed |
| Hacking hematopoiesis - emerging tools for examining variant effects. | Dis Model Mech | 2023 | 36826849 | PubTator, text mining | PubMed |
| Massively parallel characterization of psychiatric disorder-associated and cell-type-specific regulatory elements in the developing human cortex. | bioRxiv | 2023 | 36824845 | PubTator, text mining | PubMed |
| The biological role and immunotherapy of gangliosides and GD3 synthase in cancers. | Front Cell Dev Biol | 2023 | 36824365 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53335/papers?page=25